Not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.
PSC Trial Watch
Crohn'sUCRecruiting

TIDHI Mental Health in IBD Patients Study

Not applicable · Testing Healing Circuits™ sessions and self-directed Healing Circuits™ curriculum · 1 site · TIDHI Innovation Inc.

Official record & contacts on ClinicalTrials.gov ↗

In plain English

What this trial is testing

This study is testing Healing Circuits™ sessions (a behavioral program) and self-directed Healing Circuits™ curriculum (a behavioral program) as a possible treatment. Condition(s) listed: Crohn Disease (CD), Ulcerative Colitis (UC) and Inflammatory Bowel Disease (IBD).

Participants are assigned to groups by chance (randomized).

It is open-label: participants know what they are receiving.

This study does not use drug-development phases (it may test a device, diet, procedure, app, or care approach).

Who can join

Some of the main requirements, copied from the record:

There are also 5 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.

What's involved

Groups in this study

Main thing being measured

In the researchers’ words

The purpose of this study is to test the impact of Healing Circuits™; a structured mental health support model on IBD patients. The eligible study participants will be randomly divided into two groups: 1. the group receiving structured mental health support with a social worker and 2. the group receiving structured mental health support via a self-directed online curriculum. Both groups will be receiving the same…

This summary was written automatically from the official record using fixed templates (no AI), so it only says what the record says, and may leave things out.

Questions to ask your doctor and the trial team

Official details

StatusRecruiting
PhaseNot applicable
Study typeInterventional
ConditionsCrohn Disease (CD); Ulcerative Colitis (UC); Inflammatory Bowel Disease (IBD)
Lead sponsorTIDHI Innovation Inc.
CollaboratorsAmgen; Celltrion
Enrollment100 (estimated)
Start date2025-07-22
Primary completion (est.)2027-07-01
First posted2025-06-10
Last updated2026-09-29
Official titleA Randomized Evaluation of Changes in Anxiety and Depression in Inflammatory Bowel Disease Patients Comparing Structured Mental Health Support to App Based Mental Health Support in Addition to Standard of Care Medical Treatment
ClinicalTrials.gov IDNCT07013578

Interventions

Full eligibility criteria (from the record)
Inclusion Criteria:

Subjects must meet each of the following criteria for enrolment into the study:

1. Written informed consent must be obtained and documented.
2. Males and females between the ages of 18 and 75 years of age with documented diagnosis of IBD.
3. GAD7 and/or PHQ9 score of 10 - 15.
4. Ability of subject to participate fully in all aspects of this clinical trial.
5. IBD patients who plan to have ongoing medical care at TIDHI.

Exclusion Criteria:

Subjects who exhibit any of the following conditions are to be excluded from the study:

1. Plan for change in systemically delivered IBD-related medical therapy in the 3 months after screening.
2. Serious underlying psychiatric disorder such as schizophrenia or bipolar disorder.
3. Planned change in psychiatric medication, if any is being taken, within 3 months after screening.
4. History of illegal drug abuse (excluding marijuana) or alcohol abuse which in the opinion of the investigator may interfere with the subject's ability to comply with the study procedures

Locations (1)

SiteCityCountrySite status
Toronto Immune and Digestive Health InstituteNorth York, OntarioCanadaRecruiting

For contacts at each site, use the official record.

Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.